QuickView for BRCA1;jsessionid=AF094928F4039A7FE81A70EC261DFD36;jsessionid=9FA312F0FDA11A27B4394A667478D839;jsessionid=8B376F1677CED91C2959F36D4B4EB058;jsessionid=CC54AADA047367C7A1F8B8CB35BB382A;jsessionid=156D15D197B42830DD5FC779DCC4B33F (gene)

1. BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.
2. Association of common BRCA1 variants with predisposition to breast tumors in Pakistan.
3. BRCA1 protects against its own fragility.
4. BRCA1: An Endocrine and Metabolic Regulator.
5. Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovaria…

There were no clinical trials for BRCA1;jsessionid=AF094928F4039A7FE81A70EC261DFD36;jsessionid=9FA312F0FDA11A27B4394A667478D839;jsessionid=8B376F1677CED91C2959F36D4B4EB058;jsessionid=CC54AADA047367C7A1F8B8CB35BB382A;jsessionid=156D15D197B42830DD5FC779DCC4B33F